Literature DB >> 21234814

Cancer-related PRUNE2 protein is associated with nucleotides and is highly expressed in mature nerve tissues.

Eiji Iwama1, Daisuke Tsuchimoto, Teruaki Iyama, Kunihiko Sakumi, Akira Nakagawara, Koichi Takayama, Yoichi Nakanishi, Yusaku Nakabeppu.   

Abstract

Human PRUNE is thought to enhance the metastasis of tumor cells. We found that a hypothetical paralog of PRUNE, PRUNE2, binds to 8-oxo-GTP, an oxidized form of GTP. Hypothetical PRUNE2 gene consists of C9orf65 and BMCC1/BNIPXL, both of which are malignant tumor-associated genes. We isolated PRUNE2 complementary DNA and revealed that the protein is composed of 3,062 residues. C9orf65 and BMCC1/BNIPXL encode the N-terminal part (259 residues) and C-terminal part (2,729 residues) of PRUNE2, respectively. We demonstrated the endogenous full-length PRUNE2 protein (338 kDa) by Western blot and mass spectrometry. PRUNE2 bound to 8-oxo-GTP as well as GTP. The expression levels of human PRUNE2 and mouse Prune2 messenger RNA (mRNA) were highest in the dorsal root ganglia (DRG) and, to a lesser extent, in other nerve tissues. DRG neurons express higher levels of PRUNE2 in their soma compared with adjacent cells. In addition, their expression levels in the adult nerve tissues were higher than those in fetal or neonatal nerve tissues. The present study indicates that C9orf65 and BMCC1/BNIPXL are transcribed as PRUNE2 mRNA, which is translated to a large PRUNE2 protein. The nerve tissue-specific and post-development expression of PRUNE2/Prune2 suggests that PRUNE2 may contribute to the maintenance of mature nervous systems.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21234814     DOI: 10.1007/s12031-010-9490-2

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  25 in total

1.  Defense mechanism to oxidative DNA damage in glial cells.

Authors:  Takashi Iida; Akiko Furuta; Yusaku Nakabeppu; Toru Iwaki
Journal:  Neuropathology       Date:  2004-06       Impact factor: 1.906

2.  The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle.

Authors:  Diana L Ford-Speelman; Joseph A Roche; Amber L Bowman; Robert J Bloch
Journal:  Mol Biol Cell       Date:  2009-07-15       Impact factor: 4.138

3.  Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.

Authors:  J L Biedler; L Helson; B A Spengler
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

4.  Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas.

Authors:  T Machida; T Fujita; M L Ooo; M Ohira; E Isogai; M Mihara; J Hirato; D Tomotsune; T Hirata; M Fujimori; W Adachi; A Nakagawara
Journal:  Oncogene       Date:  2006-03-23       Impact factor: 9.867

5.  Hematopoietic tissue-specific expression of mouse Neil3 for endonuclease VIII-like protein.

Authors:  Kumiko Torisu; Daisuke Tsuchimoto; Yoshinori Ohnishi; Yusaku Nakabeppu
Journal:  J Biochem       Date:  2005-12       Impact factor: 3.387

Review 6.  Mutagenesis and carcinogenesis caused by the oxidation of nucleic acids.

Authors:  Yusaku Nakabeppu; Kunihiko Sakumi; Katsumi Sakamoto; Daisuke Tsuchimoto; Teruhisa Tsuzuki; Yoshimichi Nakatsu
Journal:  Biol Chem       Date:  2006-04       Impact factor: 3.915

7.  Motoneuron resistance to apoptotic cell death in vivo correlates with the ratio between X-linked inhibitor of apoptosis proteins (XIAPs) and its inhibitor, XIAP-associated factor 1.

Authors:  Daniel Perrelet; Florence E Perrin; Peter Liston; Robert G Korneluk; Alex MacKenzie; Marcel Ferrer-Alcon; Ann C Kato
Journal:  J Neurosci       Date:  2004-04-14       Impact factor: 6.167

8.  A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity.

Authors:  Y Nakabeppu; D Nathans
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

9.  Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas.

Authors:  Nathan D Price; Jonathan Trent; Adel K El-Naggar; David Cogdell; Ellen Taylor; Kelly K Hunt; Raphael E Pollock; Leroy Hood; Ilya Shmulevich; Wei Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

10.  New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression.

Authors:  Raymond A Clarke; Zhongming Zhao; An-Yuan Guo; Kathrein Roper; Linda Teng; Zhi-Ming Fang; Hema Samaratunga; Martin F Lavin; Robert A Gardiner
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

View more
  9 in total

1.  PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.

Authors:  Ahmad Salameh; Alessandro K Lee; Marina Cardó-Vila; Diana N Nunes; Eleni Efstathiou; Fernanda I Staquicini; Andrey S Dobroff; Serena Marchiò; Nora M Navone; Hitomi Hosoya; Richard C Lauer; Sijin Wen; Carolina C Salmeron; Anh Hoang; Irene Newsham; Leandro A Lima; Dirce M Carraro; Salvatore Oliviero; Mikhail G Kolonin; Richard L Sidman; Kim-Anh Do; Patricia Troncoso; Christopher J Logothetis; Ricardo R Brentani; George A Calin; Webster K Cavenee; Emmanuel Dias-Neto; Renata Pasqualini; Wadih Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-15       Impact factor: 11.205

2.  Bmcc1s, a novel brain-isoform of Bmcc1, affects cell morphology by regulating MAP6/STOP functions.

Authors:  Jessica Arama; Anne-Cécile Boulay; Christophe Bosc; Christian Delphin; Damarys Loew; Philippe Rostaing; Edwige Amigou; Pascal Ezan; Laure Wingertsmann; Laurent Guillaud; Annie Andrieux; Christian Giaume; Martine Cohen-Salmon
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

3.  Identification of novel tissue-specific genes by analysis of microarray databases: a human and mouse model.

Authors:  Yan Song; Jinsoo Ahn; Yeunsu Suh; Michael E Davis; Kichoon Lee
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

4.  KLRC3, a Natural Killer receptor gene, is a key factor involved in glioblastoma tumourigenesis and aggressiveness.

Authors:  Mathilde Cheray; Barbara Bessette; Aurélie Lacroix; Carole Mélin; Soha Jawhari; Sandra Pinet; Elise Deluche; Pierre Clavère; Karine Durand; Ricardo Sanchez-Prieto; Marie-Odile Jauberteau; Serge Battu; Fabrice Lalloué
Journal:  J Cell Mol Med       Date:  2016-09-19       Impact factor: 5.310

5.  Whole-genome sequence analysis unveils different origins of European and Asiatic mouflon and domestication-related genes in sheep.

Authors:  Ze-Hui Chen; Ya-Xi Xu; Xing-Long Xie; Dong-Feng Wang; Diana Aguilar-Gómez; Guang-Jian Liu; Xin Li; Ali Esmailizadeh; Vahideh Rezaei; Juha Kantanen; Innokentyi Ammosov; Maryam Nosrati; Kathiravan Periasamy; David W Coltman; Johannes A Lenstra; Rasmus Nielsen; Meng-Hua Li
Journal:  Commun Biol       Date:  2021-11-18

6.  Long non-coding RNA ZNF667-AS1 retards the development of esophageal squamous cell carcinoma via modulation of microRNA-1290-mediated PRUNE2.

Authors:  Ying-Juan Zheng; Tian-Song Liang; Juan Wang; Jing-Yi Zhao; Su-Nan Zhai; Dao-Ke Yang; Li-Dong Wang
Journal:  Transl Oncol       Date:  2022-04-30       Impact factor: 4.803

7.  BMCC1 is an AP-2 associated endosomal protein in prostate cancer cells.

Authors:  Janelle L Harris; Renée S Richards; Clement W K Chow; Soon Lee; Misook Kim; Marion Buck; Linda Teng; Raymond Clarke; Robert A Gardiner; Martin F Lavin
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

8.  Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration.

Authors:  Thomas C Roberts; Henrik J Johansson; Graham McClorey; Caroline Godfrey; K Emelie M Blomberg; Thibault Coursindel; Michael J Gait; C I Edvard Smith; Janne Lehtiö; Samir El Andaloussi; Matthew J A Wood
Journal:  Hum Mol Genet       Date:  2015-09-18       Impact factor: 6.150

9.  PRUNE2 inhibits progression of colorectal cancer in vitro and in vivo.

Authors:  Ting Li; Silin Huang; Wei Yan; Yu Zhang; Qiang Guo
Journal:  Exp Ther Med       Date:  2021-12-27       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.